560
Views
4
CrossRef citations to date
0
Altmetric
Review

Cost effectiveness of oseltamivir treatment of influenza: a critique of published methods and outcomes

, PhD, , PhD &
Pages 743-768 | Published online: 19 Dec 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maarten J. Postma & Baudouin A. Standaert. (2013) Economics of vaccines revisited. Human Vaccines & Immunotherapeutics 9:5, pages 1139-1141.
Read now

Articles from other publishers (3)

Andreas Handel & Mark H Ebell. (2015) Neuraminidase inhibitors for influenza: fully evaluating benefits and harms. The Lancet Respiratory Medicine 3:3, pages e7-e8.
Crossref
James R. Smith, Craig R. Rayner, Barbara Donner, Martina Wollenhaupt, Klaus Klumpp & Regina Dutkowski. (2011) Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience. Advances in Therapy 28:11, pages 927-959.
Crossref
Bruce Y. Lee, Sarah M. McGlone, Rachel R. Bailey, Ann E. Wiringa, Shanta M. Zimmer, Kenneth J. Smith & Richard K. Zimmerman. (2010) To Test or to Treat? An Analysis of Influenza Testing and Antiviral Treatment Strategies Using Economic Computer Modeling. PLoS ONE 5:6, pages e11284.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.